版本:
中国

BRIEF-Masimo Corp says appears co addressed violations contained in FDA warning letter regarding Irvine facility

June 6 Masimo Corp

* Masimo - ‍on May 26, received letter from FDA indicating FDA has completed an evaluation of Masimo's corrective actions in response to warning letter​

* Masimo Corp - ‍ based on FDA's evaluation, appears co addressed violations contained in warning letter regarding compliance practices at Irvine, California facility​

* Masimo Corp - ‍letter indicated that future FDA inspections and regulatory activities will further assess adequacy and sustainability of corrections​ Source text for Eikon: (bit.ly/2rwbfoJ) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐